mF International Limited Honored with Good MPF Employer Award 2023-24

HONG KONG,Jan. 15,2025-- mF International Limited (the "Company" or "mF International") (Nasdaq: MFI),a Hong Kong-based experienced financial trading solutions provider,is proud to

Masdar's Capacity Up By 150% to Over 50GW In Two Years Cementing Place as Global Clean Energy Leader

Masdar\'s operational,under construction and advanced pipeline capacity grew from 20GW to 51GW between 2022 and end of 2024

NEXTBIOMEDICAL Receives IDE Approval from FDA for Nexsphere-F™, an Embolic Microsphere for Use in Genicular Artery Embolization (GAE) for Knee Osteoarthritis: The U.S. RESORB Trial Launches

SEOUL,South Korea,Jan. 15,2025-- NEXTBIOMEDICAL CO.,LTD,a KOSDAQ-listed innovative medical device company in South Korea,proudly announced that it has received Investigational Device Exemption (IDE)

iMotions to Fully Integrate Affectiva's Media Analytics in Order to Establish Consolidated Global Behavioral Research Unit within Smart Eye Group

Combination of Smart Eye subsidiaries strengthens products and services,further enabling commercial and academic researchers to gain access to unparalleled insights into human behavior

(Taiwan) CMU Healthcare System and Nobel Laureate Randy Schekman Drive New Frontiers in Exosome Technology

TAICHUNG,Jan. 16,2025-- On November 2,2024,China Medical University (CMU) and Healthcare System hosted the International Forum of Extracellular Vesicles Technology and Novel Therapeutics to highlight

XDS Shoes: How to Find a Shoe Manufacturer

JINJIANG,China,Jan. 14,2025-- With the rising demand for high-quality footwear and private-label customization,finding the right shoe manufacturer has become a critical challenge for businesses in the

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch

CICC Attends the 18th Asian Financial Forum to Empower the Next Growth Engine

BEIJING,Jan. 14,2025-- OnJanuary13thand 14th,2025,the18thAsian FinancialForum2025(AFF),co-organisedby the Hong Kong Special Administrative Region (HKSAR) Government and the Hong Kong Trade Development

UCI Pro Cycling Team, Team Solution Tech - Vini Fantini Partners with Elitewheels for 2025

PISTOIA,Italy,Jan. 14,2025--Starting in January 2025,Elitewheels,a leading Chinese manufacturer of carbon fiber bicycle wheels,is excited to announce the commencement of its partnership with the UCI r

Caravelle International Group Announces New CEO and Audit Committee Chair to Trailblaze Shipping Decarbonization and Carbon Asset Management Platform

SINGAPORE,Jan. 14,2025-- Caravelle International Group (NASDAQ: HTCO),a global ocean technology company,today announcedappointment of Shixuan He as the Company\'s Chief Executive Officer and Xuanhua